{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-005035","form_type":"8-K","ticker":"CRVS","cik":"0001626971","company_name":"Corvus Pharmaceuticals, Inc.","filed_at":"2026-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.677007+00:00","generated_at":"2026-05-16T09:33:14.010281+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Corvus Pharmaceuticals suspends $100M ATM equity offering program","bullets":["Suspended $100M at-the-market offering; zero shares sold prior to suspension.","Company notified Jefferies; no sales until new prospectus supplement or registration statement filed.","Sale Agreement remains in full force and effect despite suspension.","Company cites proposed registered underwritten public offering as context."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-005035","json":"https://secwatch.observer/filing/0001104659-26-005035.json","markdown":"https://secwatch.observer/filing/0001104659-26-005035.md","text":"https://secwatch.observer/filing/0001104659-26-005035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1626971/000110465926005035/0001104659-26-005035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1626971/000110465926005035/tm263501d3_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:33:14.010281+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}